Krzysztof Jeziorski | Oncology | Best Researcher Award

Dr. Krzysztof Jeziorski | Oncology | Best Researcher Award 

Department of Gerontology and Public Health at National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

Dr. Krzysztof Grzegorz Jeziorski, MD, PhD, is a distinguished Polish oncologist with a career spanning over four decades in clinical and academic medicine. He has served as Associate Professor and Senior Assistant at the Maria Skłodowska-Curie National Research Cancer Institute in Warsaw since 1988 and continues to contribute as a Clinical Trials Consultant at the National Institute of Geriatrics, Rheumatology and Rehabilitation. Dr. Jeziorski’s professional path is marked by leadership in gastrointestinal cancer research, extensive clinical trial involvement, and international academic collaborations. A former Dean of the Faculty of Health Sciences and Social Sciences, he combines deep clinical expertise with academic excellence. He has participated in fellowships across Europe, including at the University of Oxford and the University of Padova. Renowned for his commitment to advancing cancer research, he continues to enhance his knowledge through postgraduate studies and remains actively engaged in both practice and education.

Professional Profile 

Scopus Profile
ORCID Profile 

Education

Dr. Jeziorski earned his medical degree from the Medical University of Warsaw, completing the I Medical Faculty. He later pursued advanced specialization, obtaining first and second-grade specialties in General Medicine and Chemotherapy of Cancer from the Medical Centre of Postgraduate Education. His passion for oncology led him to further achieve a specialty in Clinical Oncology and a Doctorate in Medical Sciences. In 2009, he was awarded the prestigious Habilitation degree from the Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology. Dr. Jeziorski has continually enriched his education through prestigious fellowships and academic programs, including at the Universities of Oxford, Padova, Brussels, and Cambridge. He completed several key international training programs in epidemiology and public health. Recently, he completed postgraduate studies in Clinical Trial Methodology and is currently pursuing an MBA in Clinical Research and Biomedical Innovation Management at the Medical University of Warsaw, demonstrating his continued commitment to academic and professional growth.

Experience

Dr. Jeziorski brings a wealth of experience from clinical, academic, and administrative roles. Since 1988, he has been a leading figure at the Maria Skłodowska-Curie National Research Cancer Institute in Warsaw, serving as Associate Professor and senior assistant in the Outpatient Department for GI Cancers. He has also been a Clinical Trials Consultant at the National Institute of Geriatrics, Rheumatology and Rehabilitation since 2015. Earlier in his career, he worked with institutions like the Polish Academy of Sciences and served as Dean at the State Higher School of Pope John Paul II in Biała Podlaska. His clinical foundation was established at the Central Hospital of the Medical Academy in Warsaw. Dr. Jeziorski has managed over 20 international clinical trials as a Principal Investigator, contributing significantly to cancer research. His experience integrates scientific leadership, teaching, and hands-on patient care, making him a well-rounded and respected professional in medical oncology and research.

Awards and Honors

While a detailed list of awards is not provided in the curriculum vitae, Dr. Jeziorski’s academic journey includes several significant milestones that reflect a career of distinction. He received his Second Grade Specialty in Chemotherapy of Cancer with distinction, signaling outstanding academic and clinical performance. His international fellowships at elite institutions such as the University of Oxford, University of Padova, and University of Cambridge were awarded on a competitive basis and recognize his academic merit and research potential. Additionally, his long-term appointments at top-tier research institutes and his role as a Dean suggest institutional recognition of his expertise and leadership. Acceptance into high-profile postgraduate and international research training programs—including the Erasmus Summer Program and WHO/IDF seminars—further highlight his professional standing. His ongoing pursuit of an MBA in Clinical Research reflects both personal ambition and recognition of his evolving role in biomedical innovation and management.

Research Focus on Oncology

Dr. Jeziorski’s primary research focus lies in the field of gastrointestinal oncology, where he has made sustained contributions through clinical trials and academic leadership. He has acted as Principal Investigator in over 20 international clinical trials and participated in numerous additional studies as a Sub-Investigator. His research emphasizes improving therapeutic strategies for gastrointestinal neoplasms, with a strong interest in translating scientific findings into clinical practice. Dr. Jeziorski combines rigorous methodological training with deep clinical insight, as demonstrated by his postgraduate studies in clinical trial methodology and his continued education in research management. His international fellowships enriched his approach to evidence-based medicine and interdisciplinary collaboration. Throughout his career, he has actively worked to integrate public health perspectives and epidemiology into oncology research. By maintaining roles in both clinical care and research, Dr. Jeziorski ensures his work remains patient-centered, innovative, and aligned with global advances in cancer treatment.

Publications Top Notes

  • Title: Artificial Intelligence in Oncology

    • Authors: Krzysztof Jeziorski, Robert Olszewski

    • Year: 2024

  • Title: Lost in Communication: Do Family Physicians Provide Patients with Information on Preventing Diet-Related Diseases?

    • Authors: Robert Olszewski, Justyna Obiała, Karolina Obiała, Jakub Owoc, Małgorzata Mańczak, Klaudia Ćwiklińska, Magdalena Jabłońska, Paweł Zegarow, Jolanta Grygielska, Marzena Jaciubek, et al.

    • Year: 2022

  • Title: Hyperthermia in Rheumatic Diseases. A Promising Approach?

    • Author: Krzysztof Jeziorski

    • Year: 2018

  • Title: HER2 Status in GI Adenocarcinoma (TRIO-013/LOGiC Trial)

    • Authors: Press M.F., Ellis C.E., Gagnon R.C., Jeziorski K., et al.

    • Year: 2017

  • Title: Preservation of Duodenal Passage and Quality of Life After Gastrectomy

    • Authors: Olesiński T., Szpakowski M., Saramak P., Rutkowski A., Jeziorski K.

    • Year: 2017

  • Title: Rheumatic and Oncological Diseases – Common Challenges

    • Author: Krzysztof Jeziorski

    • Year: 2017

  • Title: Lapatinib + Chemotherapy in HER2+ GI Cancers (LOGiC Trial)

    • Authors: Hecht J.R., Bang Y.-J., Qin S.K., Jeziorski K., et al.

    • Year: 2016

  • Title: Preoperative Chemoradiation vs Short-Course Therapy in Rectal Cancer

    • Authors: Bujko K., Wyrwicz L., Rutkowski A., Jeziorski K., et al.

    • Year: 2016

  • Title: Validation of QLQ-GINET21 for GI Neuroendocrine Tumors

    • Authors: Yadegarfar G., Friend L., Jeziorski K., et al.

    • Year: 2013

  • Title: Efficacy of Y-90 DOTATATE in GEP-NETs – Phase II Study

    • Authors: Cwikla J.B., Sankowski A., Jeziorski K.G., et al.

    • Year: 2009

  • Title: Radiological Efficacy of 90Y-DOTATATE in Midgut NETs

    • Authors: Cwikla J.B., Sankowski A., Jeziorski K.G., et al.

    • Year: 2009

  • Title: Abscesses After Splenectomy in Gastric/Cardia Cancer Surgery

    • Authors: Szpakowski M., Olesiński T., Jeziorski K., et al.

    • Year: 2007

  • Title: Chemotherapy for Hepatocellular and Biliary Duct Cancers

    • Author: Krzysztof Jeziorski

    • Year: 2007

  • Title: Imaging of Gastroenteropancreatic NETs – Polish Center Experience

    • Authors: Cwikla J.B., Nasierowska-Guttmejer A., Jeziorski K.G., et al.

    • Year: 2007

  • Title: Leptomeningeal Metastases of EGJ Adenocarcinoma – Case Report

    • Authors: Olesiński T., Jeziorski K., Szawłowski A.

    • Year: 2007

Conclusion

Dr. Krzysztof Jeziorski exemplifies a distinguished researcher and clinician whose contributions to gastrointestinal oncology span over four decades. His involvement in high-impact, multi-center clinical trials, coupled with authorship in internationally recognized journals such as Journal of Clinical Oncology, Annals of Oncology, and British Journal of Cancer, highlights both the breadth and relevance of his work. He has consistently collaborated with global experts and participated in pivotal studies that influence cancer treatment protocols. His recent engagement with artificial intelligence in oncology indicates a forward-thinking and adaptive research approach. Although citation metrics for many of his publications are not readily available, the scope, continuity, and quality of his work speak to his lasting impact on cancer research. Dr. Jeziorski’s blend of clinical excellence, academic leadership, and international collaboration positions him as a highly deserving candidate for the Best Researcher Award, with a legacy that bridges science, innovation, and patient-centered care.

Sukanta Nath | Cancer Research | Outstanding Scientist Award

Dr. Sukanta Nath | Cancer Research | Outstanding Scientist Award 

Research Scientist at Atal Bihari Vajpayee Regional Cancer Centre ,India

Dr. Sukanta Nath is a distinguished Research Scientist with over 13 years of experience in biotechnology and cancer research. He holds a Ph.D. in Biotechnology from Gauhati University and currently serves at the Atal Bihari Vajpayee Regional Cancer Centre, Tripura. His career spans prestigious institutions including the Indian Institute of Science, Aurigene Discovery Technologies, and Agility Diagnostics. Dr. Nath has contributed significantly to the fields of molecular biology, virology, and oncology through numerous research projects, publications, and conference presentations. He has a strong background in molecular profiling, gene expression, and cancer diagnostics, particularly Acute Myeloid Leukaemia. His dedication to advancing healthcare is also evident through his contributions to nursing intervention research in oral cancer patients. Recognized with multiple awards for research excellence and presentation, Dr. Nath continues to serve as a mentor, reviewer, and active participant in scientific forums. His work reflects a blend of academic rigor and translational medical relevance.

🔹 Professional Profile

🏆Strengths for the Award

  1. Extensive Research Experience:
    Dr. Sukanta Nath possesses more than 13 years of experience in cancer research, molecular biology, and biotechnology. His academic and professional journey through reputed institutions like IISc Bangalore, Aurigene Discovery Technologies, and Agility Diagnostics highlights a consistent dedication to scientific advancement.

  2. Specialization in Molecular Oncology:
    His Ph.D. research focused on molecular profiling in Acute Myeloid Leukemia (AML), specifically targeting key mutations such as FLT3, NPM1, and PML-RARα. This demonstrates a deep understanding of molecular cancer diagnostics.

  3. Translational and Clinical Research:
    Dr. Nath has successfully translated laboratory research into clinical practice, particularly in studies involving oral cancer patient recovery, anxiety, and fatigue. His interdisciplinary focus bridges molecular mechanisms with patient-centered care.

  4. Recognized Contributions and Awards:
    He has received notable recognitions, including the Best Researcher Award from ScienceFather and awards for oral and poster presentations at national academic events. He was also awarded the DBT-BCIL Fellowship, demonstrating government-level acknowledgment of his potential.

  5. Relevant and Recent Publications:
    His 2025 publication on high-risk HPV genotypes among women in North–East India contributes to both regional public health and global understanding of cervical cancer prevention, reflecting timely and impactful research.

  6. Mentorship and Scientific Involvement:
    Dr. Nath actively serves as a peer reviewer and mentor, supporting the broader scientific community and demonstrating a commitment to research ethics and academic development.

🎓 Education

Dr. Sukanta Nath pursued his Ph.D. in Biotechnology from Gauhati University, where he conducted impactful research on molecular profiling in Acute Myeloid Leukaemia. Prior to that, he completed his Master of Science in Biotechnology from Utkal University, where he gained foundational expertise in molecular biology and immunological techniques. His undergraduate studies were in the biological sciences, with a B.Sc. in Botany, Zoology, and Physiology from the University of Calcutta. He received his higher secondary and school education under the Tripura Board of Secondary Education. Throughout his academic journey, Dr. Nath has consistently focused on life sciences, biotechnology, and biomedical research, building a robust academic foundation that supports his ongoing professional contributions. His education was complemented by several technical training programs and hands-on experiences that prepared him for roles in molecular diagnostics, cancer biology, and clinical research.

💼 Experience

Dr. Sukanta Nath has a rich professional background with over 13 years in research and diagnostics. He is currently a Research Scientist at the Atal Bihari Vajpayee Regional Cancer Centre in Tripura, focusing on oncology and postoperative care studies. Previously, he worked as a Research Associate at the College of Fisheries, Central Agricultural University, Tripura. His industry experience includes a key role as Molecular Scientist and Quality Manager at Agility Diagnostics, Delhi. At Gauhati University, he served both as a Ph.D. scholar and Junior Research Fellow, contributing to leukemia-focused molecular studies. Dr. Nath also held a Research Associate role at Aurigene Discovery Technologies (Dr. Reddy’s Lab) and served as a Project Assistant at IISc Bangalore in a CSIR-funded cancer genomics project. His career reflects a synergy between academic research and clinical application, marked by multidisciplinary collaborations, laboratory expertise, and contributions to cancer diagnostics, infectious disease monitoring, and healthcare quality assurance.

🏆 Awards and Honors

Dr. Sukanta Nath has been honored with several prestigious awards recognizing his excellence in research and presentation. He received the Best Researcher Award from ScienceFather during the 23rd International Research Data Analysis Excellence Awards. His scientific presentations have also been lauded: he secured First Place for Best Oral Presentation at the 1st NE Hematology Tutorial (2016) and Third Place for Best Poster at the National Seminar on Climate-Smart Aquaculture and Fisheries (2019). Dr. Nath was also selected for a Biotech Consortium India Limited (BCIL) Fellowship under the DBT, Government of India. He has been acknowledged for his performance by Aurigene Discovery Technologies and has received a Certificate of Appreciation for his contributions. Furthermore, he served as a peer reviewer for journals such as Patient Preference and Adherence. His commitment to research, education, and scientific excellence is evident through these national and international recognitions.

🔬 Research Focus on Cancer Research

Dr. Sukanta Nath’s research centers on molecular biology, cancer genomics, and clinical oncology, with special emphasis on Acute Myeloid Leukaemia (AML). His Ph.D. and subsequent work have involved extensive molecular profiling of genetic mutations such as NPM1, FLT3, AML1/ETO, and PML/RARα, which are crucial in leukemia diagnostics and prognosis. At the Regional Cancer Centre in Tripura, he has pioneered studies addressing post-surgical recovery, anxiety, and fatigue in oral cancer patients, highlighting his translational focus on improving patient outcomes. His interests extend into virology, where he has worked on hepatitis genotyping and viral diagnostics. Dr. Nath also contributes to public health through studies on COVID-19 prevalence and KAP (knowledge, attitude, practice) among cancer patients. His multidisciplinary approach bridges bench-side molecular research with bedside clinical care, making his work relevant for both academic advancements and real-world medical applications. His contributions are marked by high-impact publications and collaborative studies.

📚 Publications Top Notes

Title:Molecular epidemiology and genotype distribution of genital high-risk human papillomavirus among women in North–East India

Journal:Egyptian Journal of Medical Human Genetics

Year:2025

Summary:
This study focuses on the molecular epidemiology of high-risk genital human papillomavirus (HPV) among women in North–East India. It aims to identify the prevalent HPV genotypes in the region and understand their distribution patterns. Using molecular diagnostic methods, the research highlights the frequency of various high-risk HPV strains, contributing to better-informed screening and prevention strategies, including HPV vaccination programs in the area. The study plays a significant role in regional public health planning for cervical cancer prevention.

📌 Conclusion

Dr. Sukanta Nath exemplifies a dedicated and versatile researcher whose work spans both the molecular and clinical domains of biomedical science. His 13+ years of experience reflect a blend of academic precision, research innovation, and patient-centered study design. With a Ph.D. focused on genetic profiling in leukemia and extensive research into oral cancer care, Dr. Nath has significantly contributed to the understanding and treatment of critical health conditions. His collaborations with reputed institutions and involvement in both diagnostics and therapeutic research underscore his comprehensive expertise. Beyond technical acumen, his mentorship, peer review contributions, and public health studies show a commitment to improving healthcare at multiple levels. Recognized through awards and fellowships, his contributions continue to impact oncology, virology, and molecular diagnostics. As he progresses in his career, Dr. Nath stands as a role model for translational researchers aiming to bridge the gap between laboratory science and clinical excellence.